citrulline and B16 Melanoma

citrulline has been researched along with B16 Melanoma in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Al-Omari, A; Brentville, VA; Choudhury, RH; Chua, J; Cook, KW; Daniels, I; Davis, J; Durrant, LG; Koncarevic, S; Martinez-Pinna, R; Shah, S; Skinner, A; Symonds, P; Vaghela, P; Weston, D	1
Dai, W; He, B; Li, S; Liang, Y; Sun, Y; Wang, X; Wang, Y; Zhang, H; Zhang, Q; Zhang, Y	1
Brentville, VA; Cook, K; Daniels, I; Durrant, LG; Gijon, M; Gunn, B; Metheringham, RL; Symonds, P; Xue, W	1
Feun, L; Savaraj, N	1

Reviews

1 review(s) available for citrulline and B16 Melanoma

Article	Year
Pegylated arginine deiminase: a novel anticancer enzyme agent. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:7 Topics: Amino Acid Sequence; Amino Acids; Animals; Antineoplastic Agents; Arginine; Argininosuccinate Synthase; Carcinoma, Hepatocellular; Citrulline; Clinical Trials as Topic; Dexamethasone; Dogs; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Investigational; Humans; Hydrolases; Liver Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Nude; Molecular Sequence Data; Mycoplasma hominis; Neoplasm Proteins; Neoplasms; Nutritional Requirements; Polyethylene Glycols; Rabbits; Randomized Controlled Trials as Topic; Recombinant Proteins; Skin Neoplasms; Species Specificity; Treatment Outcome	2006

Article

Year

Pegylated arginine deiminase: a novel anticancer enzyme agent.

Expert opinion on investigational drugs, 2006, Volume: 15, Issue:7

Topics: Amino Acid Sequence; Amino Acids; Animals; Antineoplastic Agents; Arginine; Argininosuccinate Synthase; Carcinoma, Hepatocellular; Citrulline; Clinical Trials as Topic; Dexamethasone; Dogs; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Investigational; Humans; Hydrolases; Liver Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Nude; Molecular Sequence Data; Mycoplasma hominis; Neoplasm Proteins; Neoplasms; Nutritional Requirements; Polyethylene Glycols; Rabbits; Randomized Controlled Trials as Topic; Recombinant Proteins; Skin Neoplasms; Species Specificity; Treatment Outcome

2006

Other Studies

3 other study(ies) available for citrulline and B16 Melanoma

Article	Year
Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy. Frontiers in immunology, 2022, Volume: 13 Topics: Animals; Citrulline; Cytokines; Endoplasmic Reticulum Chaperone BiP; Epitopes; Humans; Immunotherapy; Melanoma, Experimental; Membrane Proteins; Mice; Peptides	2022
A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers. Journal of controlled release : official journal of the Controlled Release Society, 2018, 04-10, Volume: 275 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Citrulline; Doxorubicin; Drug Delivery Systems; Drug Liberation; Integrin alphaVbeta3; Melanoma, Experimental; Mice, Inbred C57BL; Peptides, Cyclic; Prodrugs; Valine	2018
Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity. Cancer research, 2016, Feb-01, Volume: 76, Issue:3 Topics: Amino Acid Sequence; Animals; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Citrulline; Epitopes, B-Lymphocyte; HEK293 Cells; HeLa Cells; HLA-DR4 Antigen; Humans; Lung Neoplasms; Major Histocompatibility Complex; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Pancreatic Neoplasms; Peptide Fragments; Random Allocation; Transfection; Vimentin	2016